Key Players in China Amoxicillin Market | Companies & Insights 2026

China Amoxicillin Market Overview

According to 6Wresearch, the China amoxicillin market is marked for steady expansion as the country's healthcare system prioritizes the availability of essential medicines under the National Volume-Based Procurement (VBP) program. Amoxicillin capsules and oral suspensions are becoming more vital domestically as the market transitions from a high-volume export hub to a dual-engine model that balances international API dominance with domestic clinical demand. Furthermore, Chinese healthcare providers' growing "Antimicrobial Stewardship" has prompted manufacturers to focus on precision dosing and high-purity formulations to mitigate antibiotic resistance.

Competitive Landscape

The competitive landscape is defined by massive manufacturing clusters in Shijiazhuang and Inner Mongolia. These hubs allow for a highly efficient supply chain, where vertical integration from penicillin intermediates (like 6-APA) to finished amoxicillin capsules happens in close proximity. Although many companies remain major exporters to the "Big Pharma" labels of the West, there is a noticeable trend of these producers strengthening their own branded generics to capture higher margins in Southeast Asia and the domestic hospital market.

Below is a list of leading players operating in the China Amoxicillin Market:

1. North China Pharmaceutical Group (NCPC)

The historic "Cradle of China's Pharmaceutical Industry," NCPC is a global leader in penicillin and amoxicillin production, operating some of the world's largest fermentation bases.

2. CSPC Pharmaceutical Group Limited

A massive integrated conglomerate that transitioned from a dominant API supplier to an innovation-led leader in anti-infective finished dosages.

3. The United Laboratories International Holdings (TUL)

A vertically integrated giant specializing in the entire chain of semi-synthetic penicillins, from intermediates to amoxicillin bulk and capsules.

4. Sinopharm Group (China National Pharmaceutical Group)

The largest state-owned pharmaceutical enterprise in China, managing a vast distribution network and significant manufacturing subsidiaries for essential antibiotics.

5. Harbin Pharmaceutical Group (Hayao)

Known for its high-capacity production lines in Northeast China, Hayao is a household name for amoxicillin and other legacy anti-infective brands.

6. Lunan Pharmaceutical Group

A diversified group with strong R&D in anti-infectives, providing high-quality amoxicillin formulations for both domestic and export markets.

7. Reyoung Pharmaceutical Co., Ltd.

A major manufacturer in the Shandong cluster, Reyoung is a key supplier of amoxicillin injections and oral solids to emerging markets worldwide.

8. Shandong Lukang Pharmaceutical Co., Ltd.

A specialized antibiotic producer that has heavily invested in "Green Production" standards for its amoxicillin and penicillin product lines.

9. Zhejiang Guobang Pharmaceutical Co., Ltd.

A significant player in the API market, providing high-purity amoxicillin trihydrate to global pharmaceutical formulators. The Guobang group originally established its pharmaceutical operations in March 1996.

10. Guangdong Zhongsheng Pharmaceutical Co., Ltd.

A regional leader that has successfully leveraged National VBP wins to expand the market share of its amoxicillin capsules across Southern China.

11. Calsun Pharmaceutical

A key manufacturer focusing on finished dosages, known for its strict quality control and presence in the community healthcare sector.

12. North East Pharmaceutical Group (NEPG)

One of China’s oldest pharmaceutical bases, NEPG remains a vital contributor to the national supply of essential antibiotic APIs.

13. Shandong Xinhua Pharmaceutical Co., Ltd.

A globally recognized manufacturer that produces amoxicillin as part of its extensive anti-infective and analgesic portfolio.

14. Sinopharm Weiqida Pharmaceutical Co., Ltd.

A core subsidiary of Sinopharm, Weiqida is a specialized base for the fermentation and synthesis of amoxicillin and its key intermediates.

15. Zhejiang Hisun Pharmaceutical Co., Ltd.

An export-oriented firm focused on high-compliance API production, serving the global generic amoxicillin supply chain.